ConductScience.org, home

Paper33933552

The dual roles of A20 in cancer.

Shi Y and 5 others. Cancer Lett, 2021. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. The dual roles of A20 in cancer. Papers, record 33933552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33933552

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The dual roles of A20 in cancer.
PubMed
Journal
Cancer Lett
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
1.97
iCite
Revised in PubMed
2021-11-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shi YYongyu
2Wang XXinyu
3Wang JJianing
4Wang XXiaoyan
5Zhou HHuaiyu
6Zhang LLining

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Tumor Necrosis Factor alpha-Induced Protein 3Major topic
Animals
Humans
Mice

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
42844863A20 Inhibits IFN-γ Signaling in Hepatocellular Carcinoma Cells by Binding to STAT1, Compromising Anti-Tumor Immunity.Cancer Sci2026https://conductscience.org/library/papers/42844863PubMed
42704536The ubiquitin-editing enzyme A20 (TNFAIP3): mechanisms of activation, biological function, diseases and therapeutic targets.Mol Biomed2026https://conductscience.org/library/papers/42704536PubMed
42279358Comprehensive Analysis of Genomic and Phenomic Data Reveals Context-Dependent Function of A20 (TNFAIP3) in Renal Cell Carcinoma.Cancers (Basel)2026https://conductscience.org/library/papers/42279358PubMed
42095873Exosomal miR-27a-3p promotes osteosarcoma lung metastasis by negatively regulating TNFAIP3 to form a premetastatic niche.Mol Genet Genomics2026https://conductscience.org/library/papers/42095873PubMed
41405367A20 Facilitates Oxaliplatin Sensitivity in Colorectal Cancer Through Monoubiquitylation of IKK-β.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41405367PubMed
40644541Transition of cellular senescence to pyroptosis mediates recurrence of small cell lung cancer after chemotherapy.Sci Adv2025https://conductscience.org/library/papers/40644541PubMed
40214497The Role of A20 in Cancer: Friend or Foe?Cells2025https://conductscience.org/library/papers/40214497PubMed
40146279February In focus in HCB.Histochem Cell Biol2025https://conductscience.org/library/papers/40146279PubMed
40098908Tubeimoside I Inhibits the Proliferation of Liver Cancer Through Inactivating NF-κB Pathway by Regulating TNFAIP3 Expression.Drug Des Devel Ther2025https://conductscience.org/library/papers/40098908PubMed
39738689Differential expression of the ubiquitin-editing enzyme A20 in gastric biopsies indicates the severity of disease.Histochem Cell Biol2024https://conductscience.org/library/papers/39738689PubMed
39724264ZSH-2208: A novel retinoid with potent anti-tumour effects on ESCC stem cells via RARγ-TNFAIP3 axis.Clin Transl Med2025https://conductscience.org/library/papers/39724264PubMed
39678489Deubiquitinases as novel therapeutic targets for diseases.MedComm (2020)2024https://conductscience.org/library/papers/39678489PubMed
39094893The molecular mechanism of NF-κB dysregulation across different subtypes of renal cell carcinoma.J Adv Res2025https://conductscience.org/library/papers/39094893PubMed
39028490Molecular profiling of core immune-escape genes highlights TNFAIP3 as an immune-related prognostic biomarker in neuroblastoma.Inflamm Res2024https://conductscience.org/library/papers/39028490PubMed
38928333A20 in Kidney Transplantation and Autoimmunity.Int J Mol Sci2024https://conductscience.org/library/papers/38928333PubMed
38577591ASB6 as an Independent Prognostic Biomarker for Colorectal Cancer Progression Involves Lymphatic Invasion and Immune Infiltration.J Cancer2024https://conductscience.org/library/papers/38577591PubMed
38573314Identification of potential drug targets for allergic diseases from a genetic perspective: A mendelian randomization study.Clin Transl Allergy2024https://conductscience.org/library/papers/38573314PubMed
38451381The Complexity of Being A20: From Biological Functions to Genetic Associations.J Clin Immunol2024https://conductscience.org/library/papers/38451381PubMed
38322025
Integrated transcriptome and cell phenotype analysis suggest involvement of PARP1 cleavage, Hippo/Wnt, TGF-β and MAPK signaling pathways in ovarian cancer cells response to cannabis and PARP1 inhibitor treatment.
Front Genet2024https://conductscience.org/library/papers/38322025PubMed
38192819N6-methyladenosine methylation in ophthalmic diseases: From mechanisms to potential applications.Heliyon2024https://conductscience.org/library/papers/38192819PubMed

See all 29 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IGKV1-2728935PubTator's text mininghttps://conductscience.org/library/genes/28935NCBI Gene
TNFAIP37128PubTator's text mininghttps://conductscience.org/library/genes/7128NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33933552

GET https://conductscience.org/api/papers/v1/33933552/cited_by?page=2